7.60

3.12% +0.23

After Hours: 7.54 -0.06 -0.79%

Pulse Biosciences Inc (PLSE)

Overview News Price History Option Chain Discussions Forecast

Pulse Biosciences Inc stock is currently priced at $7.60, with a 24-hour trading volume of 128.90K. It has seen a +3.12% increased in the last 24 hours and a -4.88% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $7.40 pivot point. If it approaches the $7.74 resistance level, significant changes may occur.

Previous Close:

$7.37

Open:

$7.35

24h Volume:

128.90K

Market Cap:

$419.71M

Revenue:

Net Income/Loss:

$-42.21M

P/E Ratio:

-6.2295

EPS:

-1.22

Net Cash Flow:

$-33.16M

1W Performance:

+10.79%

1M Performance:

-4.88%

6M Performance:

+73.52%

1Y Performance:

+11.60%

1D Range:

$7.19

$7.81

52W Range:

$3.78

$13.62

Pulse Biosciences Inc Stock (PLSE) Company Profile

Name

Pulse Biosciences Inc

Sector

Healthcare (1189)

Industry

Medical Instruments & Supplies (60)

Phone

650-697-3939

Address

3957 Point Eden Way, Hayward, CA

Employee

Twitter

@PulseBioNPS

Next Earnings Date

2024-05-07

Latest SEC Filings

PLSE's Discussions on Twitter

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-27-21	Initiated	Stephens	Overweight
Mar-11-21	Initiated	Maxim Group	Buy
Jan-26-21	Reiterated	H.C. Wainwright	Buy
May-12-20	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-14-20	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-25-19	Initiated	H.C. Wainwright	Buy

View All

Pulse Biosciences Inc Stock (PLSE) Latest News

Oxford Industries, PVH And 3 Stocks To Watch Heading Into Monday

Benzinga

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday

Benzinga

Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday?

Benzinga

$10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

Benzinga

Insiders Buying Dave And 2 Other Stocks

Benzinga

Pulse Biosciences Inc Stock (PLSE) Financials Data

Pulse Biosciences Inc (PLSE) Net Income 2024

PLSE net income (TTM) was -$42.21 million for the quarter ending December 31, 2023, a +27.85% increase year-over-year.

Pulse Biosciences Inc (PLSE) Cash Flow 2024

PLSE recorded a free cash flow (TTM) of -$33.16 million for the quarter ending December 31, 2023, a +30.06% increase year-over-year.

Pulse Biosciences Inc (PLSE) Earnings per Share 2024

PLSE earnings per share (TTM) was -$0.89 for the quarter ending December 31, 2023, a +49.43% growth year-over-year.

Pulse Biosciences, Inc., a clinical-stage medical technology company, develops therapeutic tissue treatment platform based on its proprietary nano-pulse stimulation (NPS) technology. Its NPS is a non-thermal, precise, and focal drug-free tissue treatment technology that initiates cell death within treated tissue used in oncology, dermatology/aesthetics, minimally invasive, and veterinary applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.